Cart
sales@molnova.com
Myrcene
CAS No. 123-35-3
Myrcene( —— )
Catalog No. M20385 CAS No. 123-35-3
Myrcene is a terpene that has been found in Cannabis and has antioxidative properties.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 49 | In Stock |
|
| 25MG | 75 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMyrcene
-
NoteResearch use only, not for human use.
-
Brief DescriptionMyrcene is a terpene that has been found in Cannabis and has antioxidative properties.
-
DescriptionMyrcene is a terpene that has been found in Cannabis and has antioxidative properties.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number123-35-3
-
Formula Weight136.23
-
Molecular FormulaC10H16?
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?Ethanol : ≥ 100 mg/mL (734.05)
-
SMILESC\C(C)=C\CCC(=C)C=C
-
Chemical Name16-Octadiene 7-methyl-3-methylene-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Mespirenone
Mespirenone is a spironolactone derivative and aldosterone antagonist with diuretic effects.
-
methyl 2-benzoylamin...
methyl 2-benzoylamino-3-phenylpropyionate is a natural product found in Aspergillus flavipes.
-
20-Hydroxylucidenic ...
20-Hydroxylucidenic acid E2 is a triterpenoid compound found in Ganoderma lucidum. It exhibits significant inhibitory effects on inflammation induced by TPA . Additionally, 20-Hydroxylucidenic acid E2 can suppress the expression of EBV early antigen induced by TPA , with a IC50 of 290 mol ratio/32 pmol TPA (meaning that when the molar concentration of this compound is 290 times that of 32 pmol of TPA, it can inhibit 50% of EBV early antigen expression). Therefore, 20-Hydroxylucidenic acid E2 has potential applications in anti-inflammatory and anticancer research.
